KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Long-Term Debt Repayments (2016 - 2017)

Teladoc Health's Long-Term Debt Repayments history spans 3 years, with the latest figure at $175.0 million for Q4 2017.

  • For Q4 2017, Long-Term Debt Repayments rose 3082.4% year-over-year to $175.0 million; the TTM value through Sep 2025 reached $175.0 million, down 20.16%, while the annual FY2025 figure was $550.6 million, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q4 2017 was $175.0 million at Teladoc Health, up from $44.2 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $175.0 million in Q4 2017 and bottomed at $312000.0 in Q2 2016.
  • The 3-year median for Long-Term Debt Repayments is $5.5 million (2016), against an average of $27.2 million.
  • The largest annual shift saw Long-Term Debt Repayments skyrocketed 98.53% in 2016 before it surged 3082.4% in 2017.
  • A 3-year view of Long-Term Debt Repayments shows it stood at $562000.0 in 2015, then surged by 878.47% to $5.5 million in 2016, then soared by 3082.4% to $175.0 million in 2017.
  • Per Business Quant, the three most recent readings for TDOC's Long-Term Debt Repayments are $175.0 million (Q4 2017), $44.2 million (Q3 2017), and $2.0 million (Q1 2017).